Abstract
PF-05280014 (Trazimera) is the fourth biosimilar of the reference anti-HER2 antibody trastuzumab to be approved in the EU. It is approved for use in a......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
